Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

Individualized homeopathic treatment led to complete hair regrowth in a patient with stress-induced hair loss.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Estrogen can temporarily slow down hair growth but this can be reversed.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

The robotic hair restoration device had a high success rate and was faster than manual methods for Korean patients.

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

The survival rates of hair grafts are similar regardless of how they are trimmed.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

Different genes are active in dogs' hair growth and skin, similar to humans, which helps understand dog skin and hair diseases and can relate to human conditions.

Low-dose oral minoxidil improved hair growth in most pediatric patients with mild side effects.

Colostrum-derived exosomes can promote hair growth and may be a promising treatment for hair loss.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

More atypical club hairs may indicate Telogen Effluvium.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

A rare scalp infection in a 66-year-old woman was successfully treated, leading to full hair regrowth.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.